SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Allogene Therapeutics, Inc. – ‘8-K’ for 9/15/22 – ‘XML’

On:  Wednesday, 9/21/22, at 9:05am ET   ·   For:  9/15/22   ·   Accession #:  1737287-22-72   ·   File #:  1-38693

Previous ‘8-K’:  ‘8-K’ on / for 8/9/22   ·   Next:  ‘8-K’ on / for 10/6/22   ·   Latest:  ‘8-K’ on / for 3/14/24   ·   2 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 9/21/22  Allogene Therapeutics, Inc.       8-K:8       9/15/22   10:164K

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     35K 
 5: R1          Cover                                               HTML     45K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- allo-20220915_htm                   XML     21K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 3: EX-101.LAB  XBRL Labels -- allo-20220915_lab                     XML     67K 
 4: EX-101.PRE  XBRL Presentations -- allo-20220915_pre              XML     33K 
 2: EX-101.SCH  XBRL Schema -- allo-20220915                         XSD     10K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    16K 
10: ZIP         XBRL Zipped Folder -- 0001737287-22-000072-xbrl      Zip     16K

‘XML’   —   XBRL Instance — allo-20220915_htm

This Document is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xml:lang="en-US" xmlns="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink">
<link:schemaRef xlink:href="allo-20220915.xsd" xlink:type="simple"/>
<context id="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001737287 </identifier>
</entity>
<period>
<startDate> 2022-09-15 </startDate>
<endDate> 2022-09-15 </endDate>
</period>
</context>
<dei:EntityCentralIndexKey contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV80L2ZyYWc6NjFlZTFmNTVmNDNjNGMwMDliZTg2YzRjNTA2ODBiMDAvdGFibGU6MGFmN2E2NGQ0NTNmNDYxMzg2YmEwYzgxOTQwYzU4OTMvdGFibGVyYW5nZTowYWY3YTY0ZDQ1M2Y0NjEzODZiYTBjODE5NDBjNTg5M18xLTEtMS0xLTM4NDYw_3d6de26e-8825-454c-86ef-f0d962643a97"> 0001737287 </dei:EntityCentralIndexKey>
<dei:AmendmentFlag contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV80L2ZyYWc6NjFlZTFmNTVmNDNjNGMwMDliZTg2YzRjNTA2ODBiMDAvdGFibGU6MGFmN2E2NGQ0NTNmNDYxMzg2YmEwYzgxOTQwYzU4OTMvdGFibGVyYW5nZTowYWY3YTY0ZDQ1M2Y0NjEzODZiYTBjODE5NDBjNTg5M18yLTEtMS0xLTM4NDYw_1190835e-b9c1-4871-ae97-8f1b2249aa00"> false </dei:AmendmentFlag>
<dei:DocumentType contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGV4dHJlZ2lvbjo5MDg3MjliMjZhMzI0OTM0ODVmMTZhZTQ3MTUyYmE2ZV8xMDU_cf9504cf-5a4c-48e3-8ea8-ebe08dac22aa"> 8-K </dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGV4dHJlZ2lvbjo5MDg3MjliMjZhMzI0OTM0ODVmMTZhZTQ3MTUyYmE2ZV8yNjU_2d94da6d-e32d-4fa9-b9e3-1576f6c068fc"> 2022-09-15 </dei:DocumentPeriodEndDate>
<dei:EntityRegistrantName contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGV4dHJlZ2lvbjo5MDg3MjliMjZhMzI0OTM0ODVmMTZhZTQ3MTUyYmE2ZV8yOTI_772920a6-0bd4-4edb-a25e-a043121e7e26"> Allogene Therapeutics, Inc. </dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGFibGU6MmEwNWRjMTlkZWNkNDc0MThmZDIyYjM1YWVhOTZjNWUvdGFibGVyYW5nZToyYTA1ZGMxOWRlY2Q0NzQxOGZkMjJiMzVhZWE5NmM1ZV8wLTAtMS0xLTM4NDYw_3db3847d-4fd0-4855-a902-26dedb63e248"> DE </dei:EntityIncorporationStateCountryCode>
<dei:EntityFileNumber contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGFibGU6MmEwNWRjMTlkZWNkNDc0MThmZDIyYjM1YWVhOTZjNWUvdGFibGVyYW5nZToyYTA1ZGMxOWRlY2Q0NzQxOGZkMjJiMzVhZWE5NmM1ZV8wLTEtMS0xLTM4NDYw_3cbf2cd1-0652-4a6e-833d-c0cf426474c5"> 001-38693 </dei:EntityFileNumber>
<dei:EntityTaxIdentificationNumber contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGFibGU6MmEwNWRjMTlkZWNkNDc0MThmZDIyYjM1YWVhOTZjNWUvdGFibGVyYW5nZToyYTA1ZGMxOWRlY2Q0NzQxOGZkMjJiMzVhZWE5NmM1ZV8wLTItMS0xLTM4NDYw_b5c68643-7cc3-46b8-bec8-428877d1eb4f"> 82-3562771 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGV4dHJlZ2lvbjo5MDg3MjliMjZhMzI0OTM0ODVmMTZhZTQ3MTUyYmE2ZV8zODA_bcc34984-ddab-4372-9d68-702aac5d72c0"> 210 East Grand Avenue </dei:EntityAddressAddressLine1>
<dei:EntityAddressCityOrTown contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGV4dHJlZ2lvbjo5MDg3MjliMjZhMzI0OTM0ODVmMTZhZTQ3MTUyYmE2ZV8zODQ_18893a43-6460-4cf9-a760-1bfc00900add"> South San Francisco </dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGV4dHJlZ2lvbjo5MDg3MjliMjZhMzI0OTM0ODVmMTZhZTQ3MTUyYmE2ZV8zODg_4b50bab9-01dd-481f-94fe-f0fb8c356ee7"> CA </dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGV4dHJlZ2lvbjo5MDg3MjliMjZhMzI0OTM0ODVmMTZhZTQ3MTUyYmE2ZV8zOTE_9537ab83-9565-45a0-9fc9-28d31f0a686b"> 94080 </dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGV4dHJlZ2lvbjo5MDg3MjliMjZhMzI0OTM0ODVmMTZhZTQ3MTUyYmE2ZV81MDc_7ecacaa7-fd92-438f-8224-c950fcace43c"> 650 </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGV4dHJlZ2lvbjo5MDg3MjliMjZhMzI0OTM0ODVmMTZhZTQ3MTUyYmE2ZV81MTE_e2b0d9e3-03c8-443a-a5f1-be6ecda6b5b0"> 457-2700 </dei:LocalPhoneNumber>
<dei:WrittenCommunications contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGFibGU6ZjBkZDcwNTM3MGU5NDMxM2JhM2ViZmZhY2Q3ZWJjYzgvdGFibGVyYW5nZTpmMGRkNzA1MzcwZTk0MzEzYmEzZWJmZmFjZDdlYmNjOF8wLTEtMS0xLTM4NDYw_4c526b1d-7685-4c62-8dc0-40da49b7e70f"> false </dei:WrittenCommunications>
<dei:SolicitingMaterial contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGFibGU6ZjBkZDcwNTM3MGU5NDMxM2JhM2ViZmZhY2Q3ZWJjYzgvdGFibGVyYW5nZTpmMGRkNzA1MzcwZTk0MzEzYmEzZWJmZmFjZDdlYmNjOF8xLTEtMS0xLTM4NDYw_a344b6cd-4813-492a-9bff-a788071c7a6b"> false </dei:SolicitingMaterial>
<dei:PreCommencementTenderOffer contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGFibGU6ZjBkZDcwNTM3MGU5NDMxM2JhM2ViZmZhY2Q3ZWJjYzgvdGFibGVyYW5nZTpmMGRkNzA1MzcwZTk0MzEzYmEzZWJmZmFjZDdlYmNjOF8yLTEtMS0xLTM4NDYw_d0f84542-d47d-4e7e-bd50-eec6b7de812b"> false </dei:PreCommencementTenderOffer>
<dei:PreCommencementIssuerTenderOffer contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGFibGU6ZjBkZDcwNTM3MGU5NDMxM2JhM2ViZmZhY2Q3ZWJjYzgvdGFibGVyYW5nZTpmMGRkNzA1MzcwZTk0MzEzYmEzZWJmZmFjZDdlYmNjOF8zLTEtMS0xLTM4NDYw_4e726750-9393-491e-a388-275e18c4b06b"> false </dei:PreCommencementIssuerTenderOffer>
<dei:Security12bTitle contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGFibGU6NjhjNmIzNzgyMGRhNDViNDkwODMxNDBjOTk1YmRiYjgvdGFibGVyYW5nZTo2OGM2YjM3ODIwZGE0NWI0OTA4MzE0MGM5OTViZGJiOF8xLTAtMS0xLTM4NDYw_7012cbd3-ae88-438c-bed0-2c9467c00132"> Common Stock, $0.001 par value per share </dei:Security12bTitle>
<dei:TradingSymbol contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGFibGU6NjhjNmIzNzgyMGRhNDViNDkwODMxNDBjOTk1YmRiYjgvdGFibGVyYW5nZTo2OGM2YjM3ODIwZGE0NWI0OTA4MzE0MGM5OTViZGJiOF8xLTItMS0xLTM4NDYw_a12a2c22-f580-4832-8dbe-c48c9fc905ad"> ALLO </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGFibGU6NjhjNmIzNzgyMGRhNDViNDkwODMxNDBjOTk1YmRiYjgvdGFibGVyYW5nZTo2OGM2YjM3ODIwZGE0NWI0OTA4MzE0MGM5OTViZGJiOF8xLTQtMS0xLTM4NDYw_6b03ab00-5d83-45cf-8133-07f5bf236f07"> NASDAQ </dei:SecurityExchangeName>
<dei:EntityEmergingGrowthCompany contextRef="ief045e0d4f5146bab0f6700a472d293b_D20220915-20220915" id="id3VybDovL2RvY3MudjEvZG9jOjdmMjBlOWYyNjY2NjQ1ZGViYThhMTE2MjU2MWJhMjJhL3NlYzo3ZjIwZTlmMjY2NjY0NWRlYmE4YTExNjI1NjFiYTIyYV8xL2ZyYWc6OTA4NzI5YjI2YTMyNDkzNDg1ZjE2YWU0NzE1MmJhNmUvdGV4dHJlZ2lvbjo5MDg3MjliMjZhMzI0OTM0ODVmMTZhZTQ3MTUyYmE2ZV8xMTYw_f84700c8-d2b0-4d28-a522-b72e4e108f28"> false </dei:EntityEmergingGrowthCompany>
</xbrl>

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/02/23  Allogene Therapeutics, Inc.       424B5                  2:542K                                   Donnelley … Solutions/FA
11/02/22  Allogene Therapeutics, Inc.       S-3ASR     11/02/22    9:1.7M
↑Top
Filing Submission 0001737287-22-000072   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., Apr. 30, 11:12:08.1pm ET